BioPlus Acquisition Corp. (BIOS) |
|
10.1854 -0.015 (-0.14%)
|
12-02 14:37 |
|
Open: |
10.1854 |
Pre. Close: |
10.2 |
|
High:
|
10.1854 |
Low:
|
10.1854 |
|
Volume:
|
2,001 |
Market Cap:
|
240(M) |
|
|
|
Technical analysis |
as of: 2022-12-02 4:21:16 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 11.91 One year: 13.91 |
| Support: |
Support1: 10.12 Support2: 10.07 |
| Resistance: |
Resistance1: 10.19 Resistance2: 11.91 |
| Pivot: |
10.15  |
| Moving Average: |
MA(5): 10.17 MA(20): 10.15
MA(100): 10.04 MA(250): 0 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 87.9 %D(3): 86.9 |
| RSI: |
RSI(14): 65.6 |
| 52-week: |
High: 10.19 Low: 9.77 |
| Average Vol(K): |
3-Month: 50 (K) 10-Days: 63 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ BIOS ] has closed below upper band by 19.8%. Bollinger Bands are 60.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
10.21 - 10.26 |
10.26 - 10.3 |
|
Low:
|
10.04 - 10.11 |
10.11 - 10.17 |
|
Close:
|
10.09 - 10.19 |
10.19 - 10.28 |
|
Company Description |
|
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York. |
Headline News |
Fri, 02 Dec 2022
EA Says High-End Gaming PCs Need A BIOS Update To Play Nice With Need For Speed Unbound [UPDATED] - Hot Hardware
Fri, 02 Dec 2022
Sammy Ghansah | Staff bios | About Us | Department of Student Activities - Brandeis University
Fri, 02 Dec 2022
The Callisto Protocol: Colony Walkthrough - All Collectibles: Implant Bios, Audio Logs - Push Square
Fri, 02 Dec 2022
The Callisto Protocol: All Implant Bios Locations - Push Square
Thu, 01 Dec 2022
How to repair a malware-damaged PC - TechRadar
Wed, 30 Nov 2022
BIOS Welcomes Serial Entrepreneur Deepak Savadatti as CEO - PR Newswire
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Financial Services |
| Industry: Shell Companies |
| Shares Out. |
24 (M) |
| Shares Float |
19 (M) |
|
% Held by Insiders
|
3.7 (%) |
|
% Held by Institutions
|
87.5 (%) |
|
Shares Short
|
2 (K) |
|
Shares Short P.Month
|
2 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-0.5 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-1 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
-8 |
|
Price to Book value
|
-20.79 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-184.6 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
